Design Therapeutics DSGN
NASDAQ DSGN
$10.73 -0.37 (-3.33%)
At close: Oct 21, 2026 · 4:00 PM EDT

Design Therapeutics (DSGN) Preferred Stock Liabilities (2020)

Updated

Design Therapeutics (DSGN) recorded Preferred Stock Liabilities of $45.36 million in Q4 2020, unchanged from the prior quarter.

Analysis

Design Therapeutics (DSGN) Preferred Stock Liabilities (2020) Analysis & Trends

Starting with Q1 2020, Design Therapeutics' Preferred Stock Liabilities history includes 4 quarters.

  • Per Business Quant, the preceding three quarters came in at $45.36 million (Q3 2020), $45.36 million (Q2 2020) and $45.36 million (Q1 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Design Therapeutics 669.43 Mn -186.60 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 45.36 Mn
Sep 30, 2020 45.36 Mn
Jun 30, 2020 45.36 Mn
Mar 31, 2020 45.36 Mn
API Access

Design Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=DSGN&period=max&api_key=YOUR_API_KEY